CreoSalus Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Biotech
Founded:N/A
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

Estimated Revenue & Financials

  • CreoSalus's estimated annual revenue is currently $7.9M per year.
  • CreoSalus's estimated revenue per employee is $155,000

Employee Data

  • CreoSalus has 51 Employees.
  • CreoSalus grew their employee count by 24% last year.
  • CreoSalus currently has 1 job openings.

Executive Contacts

NameTitleEmail
Darrin SterrettFacilities And Engineering ManagerEmail Available
Charles LiPresident/CEO
Lauren KipleExecutive Assistant To The President And Ceo, Human Resources, And Facility AssistantEmail Available
Angie BlumeAssociate Director, Quality And ComplianceEmail Available
William KnappPeptide Manufacturing ManagerEmail Available
Tammy PollockDirector of Human Resources & TalentEmail Available
Wentao ZhangChief Scientific OfficerEmail Available
Seth SmithsonQuality Control ManagerEmail Available
Jaime LopezQuality DirectorEmail Available

Biotech company

keywords:Healthcare,Pharmaceuticals

51

Number of Employees

$7.9M

Revenue (est)

1

Current Jobs

24%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.7M4310%N/A
Mission Bio
$11.5M7445%N/A
Ohana Bioscienc...
$7.1M4659%N/A
Tango Therapeut...
$9M5841%N/A
OriGene Technol...
$15M97-4%N/A
Databean...seed...
N/A8N/AN/A
Rigel Pharmaceu...
$45M2904%N/A
Regenexx Corpor...
$10.9M7023%N/A
IDEXX Laborator...
N/A6379N/AN/A
Genetwister Tec...
$5.6M3633%N/A
Missing a competitor? Contribute!?
Submit

CreoSalus News

10/25/2018 - Downtown Lexington skyline to look dramatically different as City Center nears completion – Lane Report | Kentucky Business & Economic News

... as well as a pharmaceutical manufacturing facility for CreoSalus in Louisville and Blue Grass Airport's new community hangar for the airport's ...

03/29/2018 - Synthesising Difficult Phosphopeptides

N,N'-Diisopropylcarbodiimide (DIC) was purchased from CreoSalus (Louisville, KY). Piperidine was obtained from Alfa Aesar (Ward Hill, MA).

11/25/2014 - United Technologies CIO Is Changing the Retirement Game

(Geisler left in 2010 to become COO and CFO at Creosalus, a Kentucky-based life-science company.) It was very hard to leave Verizon and its ...